editorial . 2018 Nov-Dec;9(6):367–372. doi: 10.4103/idoj.IDOJ_290_18
Copyright: © 2018 Indian Dermatology Online Journal
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Table 1.
Overview of the major Indian studies reporting rituximab use in pemphigus
